HRP Anti-Plasmodium aldolase antibody (ab38905)
Key features and details
- HRP Rabbit polyclonal to Plasmodium aldolase
- Suitable for: WB, ELISA
- Reacts with: Plasmodium falciparum
- Conjugation: HRP
- Isotype: IgG
Overview
-
Product name
HRP Anti-Plasmodium aldolase antibody
See all Plasmodium aldolase primary antibodies -
Description
HRP Rabbit polyclonal to Plasmodium aldolase -
Host species
Rabbit -
Conjugation
HRP -
Tested applications
Suitable for: WB, ELISAmore details -
Species reactivity
Reacts with: Plasmodium falciparum -
Immunogen
Recombinant full length plasmodium aldolase.
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
pH: 7.00
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 0.2% BSA, 0.58% Sodium chloride, 1.19% HEPES -
Concentration information loading...
-
Purity
Immunogen affinity purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Related Products
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
- 450 nm Stop Solution for TMB Substrate (ab171529)
- 650 nm Stop Solution for TMB Substrate (ab171531)
- Immunoassay Blocking Buffer (ab171534)
- Immunoassay Blocking (BSA Free) (ab171535)
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab38905 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB | (1) |
Use a concentration of 1 µg/ml. Predicted molecular weight: 40 kDa.
|
ELISA |
Use a concentration of 0.5 µg/ml.
|
Notes |
---|
WB
Use a concentration of 1 µg/ml. Predicted molecular weight: 40 kDa. |
ELISA
Use a concentration of 0.5 µg/ml. |
Target
-
Relevance
Malaria caused by Plasmodium falciparum remains the major life-threatening parasitic infection in the world. Plasmodium aldolase is an enzyme of the parasite glycolytic pathway expressed by the blood stages of Plasmodium falciparum as well as the non-falciparum malaria parasites. Monoclonal antibodies against Plasmodium aldolase are pan-specific in their reaction and have been used in an immunochromatographic test that targets the pan malarial antigen to rapidly detect malaria cases. CATALYTIC ACTIVITY: D-fructose 1,6-bisphosphate = glycerone phosphate + D-glyceraldehyde 3-phosphate. -
Cellular localization
Cytoplasmic -
Database links
- Entrez Gene: 812007 Plasmodium falciparum
- SwissProt: Q7KQL9 Plasmodium falciparum
Datasheets and documents
-
SDS download
-
Datasheet download
References (18)
ab38905 has been referenced in 18 publications.
- Diffendall GM et al. Discovery of RUF6 ncRNA-interacting proteins involved in P. falciparum immune evasion. Life Sci Alliance 6:N/A (2023). PubMed: 36379669
- Gomes AR et al. A transcriptional switch controls sex determination in Plasmodium falciparum. Nature 612:528-533 (2022). PubMed: 36477538
- Painter HJ et al. Atypical Molecular Basis for Drug Resistance to Mitochondrial Function Inhibitors in Plasmodium falciparum. Antimicrob Agents Chemother 65:N/A (2021). PubMed: 33361312
- Tibúrcio M et al. A 39-Amino-Acid C-Terminal Truncation of GDV1 Disrupts Sexual Commitment in Plasmodium falciparum. mSphere 6:N/A (2021). PubMed: 34011691
- Nardella F et al. Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites. J Med Chem 64:10403-10417 (2021). PubMed: 34185525